Germany Disposable Hemoperfusion Market Insight
Published: 29 May 2026 | Report Format: Electronic (PDF)
The Disposable Hemoperfusion Market Future prospects can be presented by increasing cases of chronic kidney diseases, increasing demand for treatments for sepsis and increasing use of advanced blood purification technology.
Germany Disposable Hemoperfusion Market Insights and Forecasts to 2035
- In 2025, the Germany Disposable Hemoperfusion Market stood at USD 74.6 Million, establishing a strong base for future growth.
- It is anticipated to expand at a CAGR of 8.1% over 2025 to 2035, supported by Blood Purification trend.
- The market is projected to reach USD 162.8 Million by 2035, reflecting continuous long-term growth.
Notable Insights for the Germany Disposable Hemoperfusion Market
- Based on the product type, charcoal-based hemoperfusion cartridges dominate the market with about 46-50% share in 2025. Charcoal-based hemoperfusion cartridges are highly effective in removing toxins and mediators.
- Based on the application, treatment of sepsis dominates the market with about 38-42% share in 2025. Increasing incidences of infection will continue to fuel demand growth in the market.
- Extracorporeal blood purification therapies have been integrated into more than 68-72 percent of advanced intensive care units in Germany for critical care management of sepsis and multiple organ failure.
- Biocompatible adsorption technologies that more than 64 percent of next generation hemoperfusion devices use improve toxin removal, reduce risks to patients and increase treatment effectiveness.
Download the eBook (ToC)
What Makes Decisions Advisors Research Unique?
- Holistic Market Intelligence: Involves the examination of emerging trends, drivers of growth, market competitiveness, investments, and outlooks for the future.
- Modern Research Approach: Includes primary surveys, secondary studies, governmental data, company data, and data triangulation procedures in order to provide dependable forecasts and insights.
- Strategic Business Intelligence: Allows for competitive analysis, SWOT analysis, strategic consultations, and tailored solutions to make informed decisions and promote business development.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the Germany disposable hemoperfusion market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in Germany Disposable Hemoperfusion Market
- Baxter International Inc.
- Fresenius Medical Care AG & Co. KGaA
- Asahi Kasei Medical Co., Ltd.
- Jafron Biomedical Co., Ltd.
- Toray Medical Co., Ltd.
- CytoSorbents Corporation
- B. Braun SE
- Nikkiso Co., Ltd.
- Kaneka Corporation
- Medtronic plc
Recent Developments:
- In March 2025, The CytoSorbents company widened the access of their cutting-edge blood purification systems for use by European critical care facilities to enable treatment of sepsis and inflammatory diseases.
Market Segmentation:
Germany Disposable Hemoperfusion Market, By Product Type
- Charcoal-Based Hemoperfusion Cartridges
- Resin-Based Hemoperfusion Cartridges
- Others
Germany Disposable Hemoperfusion Market, By Application
- Sepsis Treatment
- Drug Poisoning
- Autoimmune Diseases
- Liver Failure Management
- Others
Germany Disposable Hemoperfusion Market, By End User
- Hospitals
- Dialysis Centers
- Ambulatory Care Centers
Expert Views:
Disposable hemoperfusion market in Germany is expected to experience high growth due to increasing number of critical care admissions, increasing integration of extracorporeal blood purification therapies and healthcare investment in renal treatments and sepsis treatment technologies.
Author: Komal and Radhika By Spherical Insights and Consulting